RBA
RBA: Stephenson Carol discloses securities transactions
Stephenson Carol reported Grant or award in RB GLOBAL INC.: 17 units of Dividend Equivalent Rights (DSUs) (derivative), dated 2026-09-17. The full Form 4 contains 4 transaction entries.
RBA
Stephenson Carol reported Grant or award in RB GLOBAL INC.: 17 units of Dividend Equivalent Rights (DSUs) (derivative), dated 2026-09-17. The full Form 4 contains 4 transaction entries.
CHCI
Holly Thomas Joseph reported Grant or award in Comstock Holding Companies, Inc.: 558.00 units of Class A Common Stock, $0.01 par value, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
CHCI
Paul David Peter reported Grant or award in Comstock Holding Companies, Inc.: 570.00 units of Class A Common Stock, $0.01 par value, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
RBA
Stein Deborah reported Grant or award in RB GLOBAL INC.: 11 units of Dividend Equivalent Rights (2024 RSUs) (derivative), dated 2026-09-17. The full Form 4 contains 3 transaction entries.
RBA
O'Day Timothy J. reported Grant or award in RB GLOBAL INC.: 9 units of Dividend Equivalent Rights (DSUs) (derivative), dated 2026-09-17. The full Form 4 contains 4 transaction entries.
RBA
Elton Robert George reported Grant or award in RB GLOBAL INC.: 129 units of Dividend Equivalent Rights (DSUs) (derivative), dated 2026-09-17. The full Form 4 contains 4 transaction entries.
RBA
Bales Brian A reported Grant or award in RB GLOBAL INC.: 9 units of Dividend Equivalent Rights (DSUs) (derivative), dated 2026-09-17. The full Form 4 contains 4 transaction entries.
CRSP
Behbahani Ali reported Other (see filing) in CRISPR Therapeutics AG: 60 units of Common Shares, dated 2025-08-06. The full Form 4 contains 2 transaction entries.
GOAI
Boulette David reported Exercise or conversion in Eva Live Inc: 4000000 units of Common Stock, dated 2026-02-17. The full Form 4 contains 3 transaction entries.
WDC
Alexy Kimberly reported Grant or award in WESTERN DIGITAL CORP: 0.5617 units of Dividend Equivalent Rights (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
WDC
Cole Martin I reported Grant or award in WESTERN DIGITAL CORP: 0.6786 units of Dividend Equivalent Rights (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
WDC
Das Manuvir reported Grant or award in WESTERN DIGITAL CORP: 0.2732 units of Dividend Equivalent Rights (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
WDC
Davis Brian Scott reported Exercise or conversion in WESTERN DIGITAL CORP: 8.386 units of Common Stock, dated 2026-09-20. The full Form 4 contains 4 transaction entries.
WDC
DOLUCA TUNC reported Grant or award in WESTERN DIGITAL CORP: 0.5617 units of Dividend Equivalent Rights (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
WDC
Feller Brad reported Grant or award in WESTERN DIGITAL CORP: 4.2424 units of Dividend Equivalent Rights (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
OOMA
Yeh Jenny C reported Sale in OOMA INC: 1747 units of Common Stock, dated 2026-09-17. The full Form 4 contains 1 transaction entry.
SNDK
Goeckeler David reported Grant or award in Sandisk Corp: 3296 units of Common Stock, dated 2026-09-17. The full Form 4 contains 16 transaction entries.
BOLT
Quinn William P. reported Purchase in Bolt Biotherapeutics, Inc.: 637 units of Common Stock, dated 2026-06-05. The full Form 4 contains 4 transaction entries.
SNDK
Visoso Luis Felipe reported 1,635 shares of Common Stock in Sandisk Corp as grants or awards dated 2026-09-17. The Form 4 was disclosed on Sep 21, 2026. These were stock awards, not open-market purchases.
BOLT
Nemec Sarah reported Purchase in Bolt Biotherapeutics, Inc.: 509 units of Common Stock, dated 2026-06-05. The full Form 4 contains 4 transaction entries.
SNDK
Pokorny Michael reported 458 shares of Common Stock in Sandisk Corp as grants or awards dated 2026-09-17. The Form 4 was disclosed on Sep 21, 2026. These were stock awards, not open-market purchases.
BOLT
Yonehiro Grant reported Sale in Bolt Biotherapeutics, Inc.: 1417 units of Common Stock, dated 2026-09-16. The full Form 4 contains 3 transaction entries.
ETRA
Dong Quehuong (Kathy) reported Conversion in Electra Therapeutics, Inc.: 455484 units of Common Stock, dated 2026-09-21. The full Form 4 contains 2 transaction entries.
GH
Hidalgo Medina Manuel reported Exercise or conversion in Guardant Health, Inc.: 232 units of Common Stock, dated 2026-09-17. The full Form 4 contains 2 transaction entries.